Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "ERSPC European Randomized Study Screening Prostate Cancer" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about ERSPC European Randomized Study Screening Prostate Cancer for you to read. Along with our medical data and news we also list ERSPC European Randomized Study Screening Prostate Cancer Clinical Trials, which are updated daily. BioPortfolio also has a large database of ERSPC European Randomized Study Screening Prostate Cancer Companies for you to search.
A new clinical study will test for the first time if MRI scans can be used for population screening to detect prostate cancer more accurately... The post
A new paper appearing in Annals of Internal Medicine used simulation modeling to try to correct for a known bias in a notable U.S. trial of prostate cancer screening, called PLCO. That study along with a large European one played an … Continue reading →
(JAMA Network) The US Preventive Services Task Force (USPSTF) recommends that men 55 to 69 who are interested in screening talk to their doctors about potential benefits and harms of screening for prostate cancer before deciding whether to undergo periodic prostate-specific antigen (PSA)-based screening. The USPSTF recommends against PSA-based screening for men 70 and older.
A new study reveals declines in prostate cancer screening and diagnoses in the United States in recent years, as well as decreases in the use of definitive treatments in men who have been diagnosed.
A BMJ Rapid Recommendation in this issue1 reviews the evidence2 behind prostate cancer screening, including the latest large trial of prostate cancer screening with the prostate-specific antigen...
After falling for two decades, prostate cancer mortality in the United States has levelled out since a government taskforce recommended against routine prostate specific antigen (PSA) screening, an...
Prostate-specific antigen (PSA) screening for prostate cancer isn't recommended unless men request the test after being informed of its potential benefits and risks, the...
The U.S. Preventive Services Task Force (USPSTF) has updated its recommendations for prostate cancer screening, now recommending that men 55 to 69 who are interested in screening talk to their doctors about potential benefits and harms of screening for prostate … Continue reading →
The U.S. Preventive Services Task Force (USPSTF) has updated its guideline for prostate cancer screening. The group now recommends that men ages 55 to 69 who are interested in screening talk to their doctors about potential benefits and harms of … Continue reading →
What you need to knowPSA testing has increased the number of men diagnosed with and treated for prostate cancer, but many of these men would never have experienced any symptoms or death from prostate...
This article addresses prostate cancer screening and the research around its potential benefits and harms.
Dr Charles Vega comments on two studies, each looking at a different issue related to prostate cancer screening. Medscape Internal Medicine
Dr Gerald Chodak discusses recent findings from a retrospective analysis on the magnitude of benefit with prostate cancer screening. Medscape Urology
(Reuters Health) - Most men shouldn't get routine prostate cancer screening because the potential benefits are small and there are clear harms, an international panel of experts concludes.
A better understanding of prostate cancer genetics may lead to more targeted screening strategies for men with a greater risk of developing the disease. Translational Andrology and Urology
Are patients being diagnosed with more advanced prostate cancer now that PSA screening recommendations have changed? Dr Chodak reviews a study seeking to answer this question. Medscape Urology
Alex H. Krist, MD, MPHDavid F. Penson, MD, MPH
Study Details Publication #: MP12-20 Prostate Health Index and Multiparametric Magnetic Resonance Imaging to Predict Prostate Cancer Grade Reclassification in Active Surveillance:When used together, Read more...
Source: UpToDateRelated MedlinePlus Pages: Prostate Cancer Screening
A panel of experts from the United Kingdom is asking whether regular screening for prostate cancer actually brings enough benefits to outweigh the risks.
(Wiley) A new study reveals declines in prostate cancer screening and diagnoses in the United States in recent years, as well as decreases in the use of definitive treatments in men who have been diagnosed.
Susan Perry In 2012, the United States Preventive Services Task Force (USPSTF) recommended against routine prostate-specific antigen (PSA)-based screening for prostate cancer. The potential harms outweigh the potential benefits, they said.Last week, the Task Force — an independent panel of experts that evaluates the latest scientific ...
The USPSTF's recently updated prostate cancer screening guidelines will challenge physicians to deliver accurate information to patients quickly and easily, argues Dr Gerald Chodak. Medscape Urology
Review in-depth clinical information, latest medical news, and guidelines on prostate cancer and prostate cancer treatment including prostate cancer surgery. Learn about prostate cancer prognosis for advanced prostate cancer.